TNOX Tanox (MM)

HOUSTON, Nov. 1 /PRNewswire-FirstCall/ -- Tanox, Inc. (NASDAQ:TNOX) will deliver a presentation at the Rodman & Renshaw Techvest Healthcare Conference Nov. 7, 2005 and at the CIBC World Markets Healthcare Conference Nov. 9 in New York City. Tanox President and CEO Nancy Chang, Ph.D., and Medical Director Stanley Lewis, M.D., will present at the Rodman conference Nov. 7 at 8:20 a.m. and at CIBC Nov. 9 at 9 a.m., EST. They will discuss the recently announced Phase 2 clinical trial results of TNX-355, other candidates in the company's drug- development pipeline and upcoming corporate milestones. Audio webcasts of the presentations will be accessible on the company Web site at http://www.tanox.com/ in the Investor Relations section. Presentation slides will be available on the site following the webcasts. About Tanox, Inc. Tanox is a biotechnology company specializing in the discovery and development of biotherapeutics based on monoclonal antibody technology. The company develops innovative therapeutic agents for the treatment of immune- mediated diseases, inflammation, infectious disease and cancer. Tanox's lead investigational therapy, TNX-355, is a humanized, anti-CD4 monoclonal antibody to treat HIV and AIDS. TNX-355 received Fast Track Status from the U.S. Food and Drug Administration and is currently in Phase 2 clinical testing. Tanox's first-approved drug, Xolair(R) (omalizumab), is the first anti-immunoglobulin E (anti-IgE) antibody to be brought to market. Xolair was developed in collaboration with Genentech, Inc. and Novartis Pharma AG and approved for marketing in the United States for adult and adolescent patients with moderate-to-severe, confirmed allergic asthma. Tanox is based in Houston, Texas and maintains a manufacturing facility in San Diego, California. Additional corporate information is available at http://www.tanox.com/ . http://www.newscom.com/cgi-bin/prnh/20050207/TNOXLOGO DATASOURCE: Tanox, Inc. CONTACT: Steve Sievert of Tanox, Inc., +1-713-578-4211, or Web site: http://www.tanox.com/

Copyright